May 21, 2026 Orion Pharma to present its first clinical data from Phase 1/2 TEADES trial of TEAD inhibitor ODM-212 at the 2026 ASCO® Annual Meeting
May 21, 2026 Intent HQ Launches IntentOne, an Agentic Opportunity Intelligence Platform for Enterprises
May 21, 2026 Graphion Energy Solutions Expands EWave Product Line with 4G GPS Tracker and Integrated Monitoring Software Platform
